TrianglePUBLICATIONS · 24249672
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2014 May
- First author
- Bagatell R
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bagatell R
- type
- Author
- name
- Norris R
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Ahern C
- type
- Author
- name
- Voss S
- type
- Author
- name
- Fox E
- type
- Author
- name
- Little AR
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Adamson PC
- type
- Author
- name
- Blaney S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bagatell R
- type
- Author
- name
- Norris R
- type
- Author
- name
- Ingle AM
- type
- Author
- name
- Ahern C
- type
- Author
- name
- Voss S
- type
- Author
- name
- Fox E
- type
- Author
- name
- Little AR
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Adamson PC
- type
- Author
- name
- Blaney S
- type
- Author
- bibliography ids
- nci-bib-4e3693cbafaeb5131384d203
- book metadata
- content sha256
- 753e58b2fcd363e7d4773255a78a10be9e90262f57ca780f0ab2686d881dbb31
- document type
- citation
- dois
- 10.1002/pbc.24874
- electronic publication date
- display
- 2013 Nov 19
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24249672
- immutable id
- pubmed:24249672@753e58b2fcd363e7d4773255a78a10be9e90262f57ca780f0ab2686d881dbb31
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 5
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 833-9
- volume
- 61
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24249672
- provenance
- batch id
- af10498814d931b53231
- provider
- NCBI PubMed ESummary
- record sha256
- 5d638c769de0d229196249fd3bc3c526bb2a0b7ce3e8a0f7cc80b768de12005a
- response sha256
- 077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
- retrieved at
- 2026-09-09T23:47:00.193465+00:00
- publication date
- display
- 2014 May
- precision
- month
- year
- 2014
- publication types
- Clinical Trial, Phase I
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group Study.
Preserved source evidence · Not medical advice